GOTHA - The Early Arthritis and Psoriasis Study of Region Västra Götaland, Sweden
Launched by VASTRA GOTALAND REGION · Dec 6, 2019
Trial Information
Current as of August 19, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with rheumatoid arthritis (RA) meeting the classification criteria of American College of Rheumatology (ACR) and/or European League Against Rheumatism (EULAR) från 2010
- • Patients with psoriatic arthritis (PsA) meeting the classification criteria of Classification for Psoriatic Arthritis (CASPAR) PsA
- • Patients with undifferentiated arthritis defined as a patients with a clear arthritis, but not meeting with established classifications criteria of any now known rheumatic disease
- • Patients with psoriasis diagnosed at a dermatology department. The patients should not have any history of joint complaints with a duration of more than 6 weeks
- • General population controls, matched for age, sex and residence of living to the included patients.
- Exclusion Criteria:
- • Inability to follow study protocol
- • Swedish language difficulties
- • Having other concomitant rheumatic diagnose (Sjögrens syndrome is not an exclusion criteria)
About Vastra Gotaland Region
Vastra Gotaland Region is a prominent healthcare organization in Sweden, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a sponsor, the region leverages its extensive network of hospitals and healthcare professionals to facilitate high-quality research initiatives that address pressing health challenges. With a commitment to ethical standards and patient safety, Vastra Gotaland Region strives to foster collaboration between researchers, clinicians, and patients, ensuring that clinical trials contribute valuable insights and advancements in medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gothenburg, , Sweden
Patients applied
Trial Officials
Eva Klingberg, Assoc. Prof
Principal Investigator
Dep of Rheumatology and Inflammation research, University of Gothenburg, Sweden
Inger Gjertsson, Prof
Principal Investigator
Dep of Rheumatology and Inflammation research, University of Gothenburg, Sweden
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials